科研之友
微信
新浪微博
Facebook
分享链接
摘要
-eleostearic acid (-ESA) has been shown to possess antitumor activity in cancer cells. However, the underlying mechanism(s) remain largely unknown. The present study was designed to investigate the antitumor effect of -ESA in breast cancer cells showing different expression levels of the human epidermal growth factor receptor 2 (HER2). -ESA inhibited cell growth and induced apoptosis in the SKBR3 and T47D breast cancer cell lines. The mechanism by which cell growth was inhibited involved G(0)/G(1) and G(2)/M cell cycle phase arrest. The MTT assay showed that SKBR3 cells are more sensitive to -ESA compared to T47D cells. Western blot analysis revealed that -ESA treatment not only reduced HER2/HER3 protein expression, but also increased the level of phosphorylated phosphatase and tensin homolog protein (PTEN), which led to decreased levels of phosphorylated Akt. Inactive Akt further reduced phosphorylation of glycogen synthase kinase-3 (GSK-3) and B-cell lymphoma 2 (Bcl-2)-associated death promoter (BAD) proteins. Furthermore, the level of the anti-apoptotic protein Bcl-2 was found to be reduced following -ESA treatment. Notably, nuclear factor B (NF-B) was activated by -ESA treatment. Data of the present study showed that the antitumor activity of -ESA is at least partly mediated by reduction of the HER2/HER3 heterodimer protein level, activation of the Akt/BAD/Bcl-2 apoptotic pathway and inhibition of the Akt/GSK-3 survival pathway in the two breast cancer cell lines investigated in this study. Therefore, -ESA may be considered a beneficial dietary factor for the prevention and treatment of invasive breast cancer in cells overexpressing HER2.
- 出版日期2014-3
- 单位宁波市医疗中心李惠利医院; 宁波大学
